Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Dr. Allen and Charlotte Ginsburg commit $31 million to UCLA Research Park, David Geffen School of Medicine at UCLA


News provided by

UCLA Health

Nov 05, 2025, 11:00 ET

Share this article

Share toX

Share this article

Share toX

Local philanthropists' estate gift invests in graduate education in the biomedical sciences, groundbreaking research and capital for pioneering work

LOS ANGELES, Nov. 5, 2025 /PRNewswire/ -- UCLA Health has received a $31 million commitment from Dr. Allen and Charlotte Ginsburg and their research foundation to advance biomedical research at the UCLA Research Park. The latest pledge brings the couple's total giving to UCLA to $60 million.

The pledge is designed to foster generations of leaders, advance discovery science and provide the laboratory resources needed to support the work. The commitment provides holistic funding for new breakthroughs in basic, translational and clinical science — and the people who lead these efforts.

Continue Reading
“Allen and Charlotte Ginsburg’s visionary contribution to the David Geffen School of Medicine and the UCLA Research Park will have a transformative impact,” said UCLA Chancellor Julio Frenk. “Their generosity supports our acceleration of breakthrough research into real-world solutions — deepening collaboration across disciplines, feeding innovation, and strengthening our ties with industry and the broader community.” Photo: Reed Hutchinson / UCLA
“Allen and Charlotte Ginsburg’s visionary contribution to the David Geffen School of Medicine and the UCLA Research Park will have a transformative impact,” said UCLA Chancellor Julio Frenk. “Their generosity supports our acceleration of breakthrough research into real-world solutions — deepening collaboration across disciplines, feeding innovation, and strengthening our ties with industry and the broader community.” Photo: Reed Hutchinson / UCLA

"Allen and Charlotte Ginsburg's visionary contribution to the David Geffen School of Medicine and the UCLA Research Park will have a transformative impact," said UCLA Chancellor Julio Frenk. "Their generosity supports our acceleration of breakthrough research into real-world solutions — deepening collaboration across disciplines, feeding innovation, and strengthening our ties with industry and the broader community. Together, we're building a stronger hub for discovery — one that brings bold ideas to life and extends UCLA's reach far beyond campus."

"We are immensely thankful to Allen and Charlotte for their generosity and philanthropic leadership," said Dr. John Mazziotta, vice chancellor of UCLA Health Sciences and CEO of UCLA Health, who played a key role in realizing the acquisition of the research park and the establishment of the California Institute for Immunology and Immunotherapy. "Their commitment will help us champion scientific investigators and their work at every turn, where aspiring faculty face the most imposing challenges of their young careers: building a research team and portfolio. The Ginsburgs understand this talent bottleneck and confront it directly with comprehensive support."

The gift directs $11 million to the Dr. Allen and Charlotte Ginsburg Fund for Graduate Student Support, which will provide financial and research funding for graduate students, doctoral trainees and postdoctoral candidates. The transition from trainee to faculty after extensive academic work is particularly difficult for early-career candidates. Awards will subsidize research, tuition, books, housing and similar expenses that enable these aspiring research faculty to complete their education, be mentored in a world-class environment and launch their careers with momentum.

Recipients selected by the David Geffen School of Medicine at UCLA through a competitive review will be recognized as Ginsburg Scholars/Fellows. Successive generations of these fellows and scholars will form cohorts of highly talented biomedical researchers.

The next $10 million will create the Dr. Allen and Charlotte Ginsburg Biomedical Frontiers Fund. The medical school dean will convene a selection committee to award research funding to some of the most promising biomedical investigations and teams from the school of medicine, quantum innovation hub and the California Institute for Immunology and Immunotherapy, who will conduct their work at the UCLA Research Park.

The final $10 million will support the capital needs of the UCLA Research Park, including laboratories and unrivaled tools that will underpin the research planned for the park.

In recognition of the couple's cumulative philanthropy, UCLA will name the Dr. Allen and Charlotte Ginsburg Foyer, the Dr. Allen and Charlotte Ginsburg Paseo and the Dr. Allen and Charlotte Ginsburg Innovation Bridge in the UCLA Research Park.

Together, these namings honor the couple's significant investment — past, present and future — in biomedical research, scientists and the labs where they work. A previous $29 million gift enabled UCLA to establish the UCLA Dr. Allen and Charlotte Ginsburg Center for Precision Genomic Medicine.

The Ginsburgs, who have been married for more than 45 years and reside on the Palos Verdes Peninsula, said this latest commitment is one of many that reflect their focus on people, projects and institutions that work to improve human health.

"Charlotte and I believe that science plays an outsized role in clinical care. Our gift seeks to ensure that the generations who follow have the resources, tools and mentors to continue to advance human health and well-being," said philanthropist and real estate entrepreneur Dr. Allen Ginsburg. "The UCLA Research Park is the latest example of UCLA's focus on generating discoveries that benefit patients everywhere."

Ginsburg, a retired ophthalmologist who completed his residency at UCLA in 1963, practiced medicine in Redondo Beach for many years.

"This is also why we have created the Dr. Allen and Charlotte Ginsburg Research Foundation: so that our investment in research and innovation in Southern California will live on beyond our lifetimes," added Charlotte Ginsburg, a performing arts patron and enthusiast. 

"This extraordinary gift exemplifies how vision and generosity can accelerate discovery," said Dr. Steven Dubinett, dean of the Geffen School of Medicine. "It underscores the essential role of philanthropy in advancing science and cultivating the next generation of innovators. I am deeply grateful to the Ginsburgs for their profound partnership as we build an unparalleled ecosystem at the UCLA Research Park."

SOURCE UCLA Health

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Steven C. Gordon Family Foundation commits $20 million to expand capacity of Ronald Reagan UCLA Medical Center

Steven C. Gordon Family Foundation commits $20 million to expand capacity of Ronald Reagan UCLA Medical Center

UCLA Health has received a $20 million commitment from longtime philanthropists and advisory board leaders Laurie and Steven C. Gordon to help expand ...

More Releases From This Source

Explore

Education

Education

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Corporate Social Responsibility

Corporate Social Responsibility

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.